| Open Document File Size: 1,19 MBShare Result on Facebook
Company Novartis Pharmaceuticals Corporation / / Country United States / / Facility One Health Plaza / / / IndustryTerm healthcare professionals / / MedicalCondition ataxia / fatal infections / PML infection / systemic lupus erythematosus / HIV / opportunistic infections / disease / neutropenia / lymphomas / latent infection / Hemiparesis / Progressive Multifocal Leukoencephalopathy / white matter disease / hypersensitivity / infection / SLE / lymphoma and other neoplasms / Infections / sepsis / / MedicalTreatment contraception / immunosuppression / renal transplants / immunosuppressive therapy / counseling / organ transplant / renal transplant / heart transplant / contraceptive methods / / MusicAlbum Subject / / Organization Food and Drug Administration / DOSAGE AND ADMINISTRATION / ON PML / / Person Stephen Cunningham / / / Position Chief Scientific Officer / US Clinical Development / physician / neurologist / / Product cyclosporine / MYFORTIC / cyclophosphamide / azathioprine / / RadioStation NOVA / / Technology diagnostic tests / / URL http /
SocialTag |
Microsoft Word - NOMU0855_NDA[removed]Myfortic - PML DHCP letter 13May08_clean_V2.doc